SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-017653
Filing Date
2009-03-20
Accepted
2009-03-20 15:19:00
Documents
1
Period of Report
2008-10-21

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c82900_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c82900_4x0.xml 4 10258
  Complete submission text file 0001209191-09-017653.txt   13032
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Issuer) CIK: 0001144062 (see all company filings)

IRS No.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON ST. SUITE 401 BOSTON MA 02116
Business Address 535 BOYLSTON ST. SUITE 401 BOSTON MA 02116 617-375-3000
Mast Credit Opportunities I Master Fund LTD (Reporting) CIK: 0001336625 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32947 | Film No.: 09696082

Mailing Address 535 BOYLSTON STREET SUITE 401 BOSTON MA 02116
Business Address 535 BOYLSTON STREET SUITE 401 BOSTON MA 02116 617-375-3000
Mast Capital Management LLC (Reporting) CIK: 0001429074 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-32947 | Film No.: 09696081